Nichols & Pratt Advisers LLP Organon & Co. Transaction History

Nichols & Pratt Advisers LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $902,310 - $1.11 Million	-28,500 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $32,551 - $42,075	-1,069 Reduced 3.62%	28,500 $995,000
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $56,565 - $73,257	-1,973 Reduced 6.26%	29,569 $901,000
Q3 2021 Nov 01, 2021	SELL	$28.63 - $35.64 $755,660 - $940,682	-26,394 Reduced 45.56%	31,542 $1.05 Million
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $1.65 Million - $2.2 Million	57,936 New	57,936 $1.75 Million

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.87B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.